SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
SRTA

Strata Critical Medical, Inc. (NASDAQ:SRTA)

US · Delayed Price · Currency is USD
Also listed: BLDEHealthcare · Medical - Care Facilities
4.76+0.10 (+2.15%)
 
Market cap
$421M
Analyst consensus
Listed since
Nov 5, 2019
Insider Score
––Not scored
SRTA Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

SRTA Stock Insider Trading Activity

SRTA stock’s insider trading shows 2 sales on the open market for an estimated $203.79K by company insiders over the last 6 months.

Not enough price history.

Insider Trading Activity (Form 4 Filings)

An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.

Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
InsiderActionSharesAvg CostTotalΔ HoldingsHeld AfterDateGradeForm 4
Tomkiel Melissa M.
CEO
Award177,858—— 8.6%2,244,475Sep 24, 2026— Form 4
Tomkiel Melissa M.
CEO
Tax withheld90,797$5.27$478.50K 4.0%2,153,678Sep 24, 2026— Form 4
Heyburn William A.
CEO
Award177,858—— 10.6%1,856,206Sep 24, 2026— Form 4
Heyburn William A.
CEO
Tax withheld98,356$5.27$518.34K 5.3%1,757,850Sep 24, 2026— Form 4
Wunsch Scott M
CEO
Tax withheld5,711$5.31$30.33K 0.9%663,043Sep 8, 2026— Form 4
Tomkiel Melissa M.
CEO
Tax withheld29,730$5.31$157.87K 1.4%2,066,617Sep 8, 2026— Form 4
Heyburn William A.
CEO
Tax withheld31,671$5.31$168.17K 1.9%1,678,348Sep 8, 2026— Form 4
Verdetto Louis R.
CEO
Tax withheld5,697$5.31$30.25K 0.5%1,128,096Sep 8, 2026— Form 4
Cohen Amir
Other
Tax withheld4,645$5.31$24.66K 2.6%177,154Sep 8, 2026— Form 4
Love Reginald
Director
Sell5,091$5.75$29.27K 3.4%146,481Aug 10, 2026— Form 4
Wunsch Scott M
CEO
Tax withheld13,992$5.09$71.22K 2.0%668,754Jul 31, 2026— Form 4
Cohen Amir
Other
Tax withheld34,015$5.09$173.14K 15.8%181,799Jul 31, 2026— Form 4
Heyburn William A.
CEO
Tax withheld199,209$5.09$1.01M 10.4%1,710,019Jul 31, 2026— Form 4
Tomkiel Melissa M.
CEO
Tax withheld212,309$5.09$1.08M 9.2%2,096,347Jul 31, 2026— Form 4
LAUCK ANDREW
Director
Award35,260—— 26.0%170,902Jul 30, 2026— Form 4
Heyburn William A.
CEO
Award181,071—— 11.7%1,730,068Jul 30, 2026— Form 4
Heyburn William A.
CEO
Award179,160—— 10.4%1,909,228Jul 30, 2026— Form 4
Cohen Amir
Other
Award27,420—— 14.6%215,814Jul 30, 2026— Form 4
Cohen Amir
Other
Award41,786—— 28.5%188,394Jul 30, 2026— Form 4
Tomkiel Melissa M.
CEO
Award206,953—— 9.8%2,308,656Jul 30, 2026— Form 4
Tomkiel Melissa M.
CEO
Award208,929—— 11.0%2,101,703Jul 30, 2026— Form 4
Love Reginald
Director
Award37,675—— 33.1%151,572Jul 30, 2026— Form 4
Cook William L. III
Director
Award44,438—— 83.5%97,671Jul 30, 2026— Form 4
PHILIP EDWARD M
Director
Award30,913—— 13.2%265,078Jul 30, 2026— Form 4
WIESENTHAL ROBERT S
Director
Award50,234—— 1.0%5,325,896Jul 30, 2026— Form 4
Wunsch Scott M
CEO
Award57,172—— 9.1%682,746Jul 30, 2026— Form 4
Tomkiel Melissa M.
CEO
Sell29,730$5.87$174.52K 1.5%1,892,774Jun 8, 2026— Form 4
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
  • Sell (S) — Open-market or private sale
  • Award (A) — Grant or award from the company, not a purchase
  • Tax withheld (F) — Shares withheld to pay tax or an exercise price
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.